TY  - GEN
AU  - Siegfried,Jill M
AU  - Gubish,Christopher T
AU  - Rothstein,Mary E
AU  - Henry,Cassandra
AU  - Stabile,Laura P
TI  - Combining the multitargeted tyrosine kinase inhibitor vandetanib with the antiestrogen fulvestrant enhances its antitumor effect in non-small cell lung cancer
SN  - 1556-1380
PY  - 2012///0614
KW  - Animals
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Apoptosis
KW  - drug effects
KW  - Blotting, Western
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Cell Proliferation
KW  - Drug Synergism
KW  - Enzyme-Linked Immunosorbent Assay
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Estradiol
KW  - analogs & derivatives
KW  - Estrogen Receptor Modulators
KW  - pharmacology
KW  - Estrogens
KW  - Female
KW  - Fluorescent Antibody Technique
KW  - Fulvestrant
KW  - Humans
KW  - Immunoenzyme Techniques
KW  - Lung Neoplasms
KW  - Mice
KW  - Mice, SCID
KW  - Piperidines
KW  - Protein Kinase Inhibitors
KW  - Protein-Tyrosine Kinases
KW  - Quinazolines
KW  - RNA, Messenger
KW  - genetics
KW  - Real-Time Polymerase Chain Reaction
KW  - Tumor Cells, Cultured
KW  - Vascular Endothelial Growth Factor A
KW  - Vascular Endothelial Growth Factor Receptor-3
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1097/JTO.0b013e31824177ea
ER  -